zdmeЗдоровье мегаполисаCity Healthcare2713-2617ГБУ «НИИОЗММ ДЗМ»10.47619/2713-2617.zm.2025.v.6i2;74-84zdme-220Research ArticleОБЗОРЫREVIEWSК вопросу о разработке PROМ в рамках реализации ценностноориентированного здравоохраненияOn the Issue of Developing PROM as Part of the Value-based Healthcarehttps://orcid.org/0000-0001-8397-8327БударинаЮ. В.BudarinaYu. V.

Бударина Юлия Викторовна – научный сотрудник 

115088, г. Москва, ул. Шарикоподшипниковская, д. 9 

Yuliya V. Budarina – Researcher 

9, Sharikopodshipnikovskaya ul., 115088, Moscow, 

ElbekYV1@zdrav.mos.ruНаучно-исследовательский институт организации здравоохранения и медицинского менеджмента Департамента здравоохранения города МосквыResearch Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department202527062025627484Copyright © Бударина Ю.В., 20252025Бударина Ю.В.Budarina Y.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.city-healthcare.com/jour/article/view/220

Актуальность. Здравоохранение, основанное на ценностях, становится основным лейтмотивом реструктуризации и совершенствования современных систем здравоохранения во всем мире. Во главу угла ставится ценность медицинской помощи для пациента, поэтому для принятия действенных решений важно измерять эффект лечения с учетом данных, сообщаемых пациентами. В статье дается краткая характеристика понятий результатов, сообщаемых пациентами (PRO), показателей для их измерения (PROМ) и их значимость в ценностно-ориентированном здравоохранении. На основе анализа публикаций зарубежных исследователей рассмотрены основные принципы и этапы формирования PROM с детализацией отдельных элементов и сгенерирована схема процесса разработки PROМ. Ввиду того что в российском здравоохранении использование PROM пока не получило широкого распространения и учитывая признанную эффективность этого инструмента при реализации инициатив ценностно-ориентированного здравоохранения (ЦОЗ) за рубежом, изучение подходов к разработке и выбору PROM становится актуальным трендом. Цель. Анализ подходов зарубежных исследователей к разработке и выбору PROM для внедрения в практику отечественного здравоохранения. Материалы и методы. Материалом для написания статьи послужил контент-анализ научной литературы, размещенной в базах данных Springer Nature (портфель журналов BMC), eLIBRARY. Отбирались публикации, посвященные проблематике измерения результатов, сообщаемых пациентами и процессу их разработки, по ключевым словам outcome indicators reported by patients; PROM; development; value-based healthcare. Дополнительно использовались общенаучные методы познания: сопоставление, обобщение, системно-структурный и аналитический методы. Результаты и их обсуждение. Рассмотрены основные типы результатов, сообщаемых пациентами, – PRO, и виды показателей для их измерения – PROM. Проанализированы результаты исследований и мнения зарубежных ученых по разработке PROM. Систематизированы принципы и этапы формирования PROM и сгенерирована схема процесса разработки PROМ для любых областей измерения и применения, которая может стать методологической базой для разработки и внедрения PROM на российский рынок здравоохранения.

Background. Value-based healthcare is becoming the main theme of restructuring and improving modern healthcare systems around the world. The value of medical care for the patient is at the forefront; therefore, in order to make effective decisions, it is important to measure the effect of the treatment by taking into account the data reported by patients. This article provides a brief description of the concepts of patient-reported outcomes (PROs), indicators for measuring them (PROMs) and their significance in value-based healthcare. Based on the analysis of foreign publications, the basic principles and stages of the formation of PROMs with detailed descriptions of separate elements are considered, and a scheme of the PROM development process is generated. Since the use of PROM in Russian healthcare has not yet widely used, but have proven effective in supporting value-based healthcare initiatives abroad, exploring methods for developing and selecting these measures is becoming a relevant trend. The goal is to analyze the approaches of foreign researchers to the development of PROM and choosing it for implementation in Russian healthcare. Materials and Methods. This review is based on the content analysis of scientific literature published in the Springer Nature databases (BMC journal portfolio) and eLibrary.ru. It includes publications on the problems of measuring the PROs and the process of their development selected using the following keywords: outcome indicators reported by patients, PROM, development, and value-based healthcare. Additionally, general scientific methods of cognition were used: comparison, generalization, system-structural and analytical methods. Results. This article considers the main types of patient-reported outcomes — PROs — and types of indicators for their measurement — PROMs. It also analyzes the results of research and opinions of foreign scientists on the development of PROM. The principles and stages of PROM development are systematized, and a scheme of the PROM development process for any areas of measurement and application is generated — a possible methodological basis for the development and implementation of PROM in the Russian healthcare market.

ценностно-ориентированная модель здравоохраненияPROPRОMпациентопроcникианкетыпоказателиvalue-based healthcarePROPROMpatientsurveysquestionnairesmeasuresReferencesХарисов А.М., Сухотерин А.Ф., Селезнев П.С. и др. Трансформация здравоохранения к пациентоориентированной модели. Бюллетень Национального научно-исследовательского института общественного здоровья имени Н.А. Семашко. 2019;3-4:96-104. https://doi.org/10.25742/NRIPH.2019.03.011Kharisov A.S., Sukhoterin A.F., Seleznev P.S., et al. Health Transformation to a Parent-Oriented Model. Bulletin of Semashko National Research Institute of Public Health. 2019;3-4:96-104. https://doi.org/10.25742/NRIPH.2019.03.011. (In Russ.)Мусина Н.З., Омельяновский В.В., Гостищев Р.В. и др. Концепция ценностно-ориентированного здравоохранения. Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. 2020;13(4):438-451. https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.042Musina N.Z., Omel'janovskij V.V., Gostishhev R.V., et al. The concept of value-based healthcare. Farmakoekonomika. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020;13(4):438-451. https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.042. (In Russ.)Мухина С.М., Орлова Е.В. Исходы, сообщаемые пациентами: обзор направлений применения. Реальная клиническая практика: данные и доказательства. 2022;2(2):1-7. https://doi.org/10.37489/2782-3784-myrwd-12Muhina S.М., Orlova E.V. Patient-reported outcomes: an overview of application directions. Real-World Data & Evidence. 2022; 2(2):1-7. https://doi.org/10.37489/2782-3784-myrwd-12. (In Russ.)Galletta M., Piazza M.F., Meloni S.L., Chessa E., Piras I., Arnetz J.E., D'Aloja E. Patient Involvement in Shared Decision-Making: Do Patients Rate Physicians and Nurses Differently? Int J Environ Res Public Health. 2022;19(21):14229. https://doi.org/10.3390/ijerph192114229Galletta M., Piazza M.F., Meloni S.L., Chessa E., Piras I., Arnetz J.E., D'Aloja E. Patient Involvement in Shared Decision-Making: Do Patients Rate Physicians and Nurses Differently? Int J Environ Res Public Health. 2022 Oct 31;19(21):14229. https://doi.org/10.3390/ijerph192114229. PMID: 36361109; PMCID: PMC9656720.Moloczij N., Gough K., Solomon B., et al. Development of a hospital-based patient-reported outcome framework for lung cancer patients: a study protocol. Health Qual Life Outcomes. 2018;16:10. https://doi.org/10.1186/s12955-017-0837-zMoloczij N., Gough K., Solomon B., et al. Development of a hospital-based patient-reported outcome framework for lung cancer patients: a study protocol. Health Qual Life Outcomes. 2018;16:10. https://doi.org/10.1186/s12955-017-0837-zWilson R. Patient led PROMs must take centre stage in cancer research. Res Involv Engagem. 2018;4:7. https://doi.org/10.1186/s40900-018-0092-4Wilson R. Patient led PROMs must take centre stage in cancer research. Res Involv Engagem 2018;4:7. https://doi.org/10.1186/s40900-018-0092-4Kargo A.S., Coulter A., Jensen P.T., et al. Proactive use of PROMs in ovarian cancer survivors: a systematic review. J Ovarian Res. 2019;12:63. https://doi.org/10.1186/s13048-019-0538-9Kargo A.S., Coulter, A., Jensen P.T., et al. Proactive use of PROMs in ovarian cancer survivors: a systematic review. J Ovarian Res 2019;12:63. https://doi.org/10.1186/s13048-019-0538-9Moss M.C.L., Aggarwal A., Qureshi A., et al. An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice. Health Qual Life Outcomes. 2021;19:20. https://doi.org/10.1186/s12955-020-01648-xMoss, M.C.L., Aggarwal, A. Qureshi A., et al. An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice. Health Qual Life Outcomes. 2021;19:20. https://doi.org/10.1186/s12955-020-01648-xSørensen N.L., Hammeken L.H., Thomsen J.L., et al. Implementing patient-reported outcomes in clinical decision-making within knee and hip osteoarthritis: an explorative review. BMC Musculoskelet Disord. 2019;20:230. https://doi.org/10.1186/s12891-019-2620-2Sørensen N.L., Hammeken L.H., Thomsen J.L., et al. Implementing patient-reported outcomes in clinical decision-making within knee and hip osteoarthritis: an explorative review. BMC Musculoskelet Disord. 2019;20:230. https://doi.org/10.1186/s12891-019-2620-2Pronk Y., van der Weegen W., Vos R., et al. What is the minimum response rate on patient-reported outcome measures needed to adequately evaluate total hip arthroplasties? Health Qual Life Outcomes. 2020;18:379. https://doi.org/10.1186/s12955-020-01628-1Pronk Y., van der Weegen W., Vos R., et al. What is the minimum response rate on patient-reported outcome measures needed to adequately evaluate total hip arthroplasties?. Health Qual Life Outcomes. 2020;18:379. https://doi.org/10.1186/s12955-020-01628-1Oliveira H.C., Hayashi D., Carvalho S.D.L., et al. Quality of measurement properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: a systematic review and metaanalysis. Syst Rev. 2023;12:222. https://doi.org/10.1186/s13643-023-02340-zOliveira H.C., Hayashi D., Carvalho S.D.L., et al. Quality of measurement properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: a systematic review and metaanalysis. Syst Rev. 2023;12:222. https://doi.org/10.1186/s13643-023-02340-zColes T.M., Hernandez A.F., Reeve B.B., et al. Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials. Health Qual Life Outcomes. 2021;19:164. https://doi.org/10.1186/s12955-021-01800-1Coles T.M., Hernandez A.F., Reeve B.B., et al. Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials. Health Qual Life Outcomes. 2021;19:164. https://doi.org/10.1186/s12955-021-01800-1Хатьков И.Е., Минаева О.А., Домрачев С.А. и др. PROM – современный подход к оценке качества жизни пациентов с онкологическими заболеваниями. Терапевтический архив. 2022;94(1):122-128. https://doi.org/10.26442/00403660.2022.01.201343Hat'kov I.E., Minaeva O.A., Domrachev S.A., et al. PROM is a modern approach to assessing the quality of life of patients with cancer. Therapeutic Archive. 2022; 94(1):122-128. https://doi.org/10.26442/00403660.2022.01.201343. (In Russ.)van Silfhout N.Y., van Muilekom M.M., van Karnebeek C.D., et al. PROs for RARE: protocol for development of a core patient reported outcome set for individuals with genetic intellectual disability. Orphanet J Rare Dis. 2024;19:354. https://doi.org/10.1186/s13023-024-03264-0van Silfhout N.Y., van Muilekom M.M., van Karnebeek C.D., et al. PROs for RARE: protocol for development of a core patient reported outcome set for individuals with genetic intellectual disability. Orphanet J Rare Dis. 2024;19:354. https://doi.org/10.1186/s13023-024-03264-0.Стеклов В.И., Ким Е.А., Крайнюков П.Е. и др. Методы оценки качества жизни больных с нарушениями ритма сердца. Вестник аритмологии. 2021;28(1):55-63. https://doi.org/10.35336/VA-2021-1-55-63Methods for assessing the quality of life of patients with cardiac arrhythmias / V. I. Steklov, E. A. Kim, P. E. Krajnjukov et al. // Journal of Arrhythmology. 2021;28(1):55-63. https://doi.org/10.35336/VA-2021-1-55-63. (In Russ.)Боровская В.Г., Касимова А.Р. Обзор руководств от FDA для вовлечения пациента в процесс разработки медицинских продуктов и принятия нормативных решений. Реальная клиническая практика: данные и доказательства. 2023;3(2):1-9. https://doi.org/10.37489/2782-3784-myrwd-31Borovskaja V.G., Kasimova A.R. Review of guidelines from the FDA for patient involvement in the process of developing medical products and making regulatory decisions. Real-World Data & Evidence. 2023;3(2):1-9. https://doi.org/10.37489/2782-3784-myrwd-31. (In Russ.)Narita A., Koto Y., Noto S., et al. Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan. Orphanet J Rare Dis. 2024;19:11. https://doi.org/10.1186/s13023-024-03264-0Narita A., Koto Y., Noto S., et al. Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan. Orphanet J Rare Dis. 2024;19:11. https://doi.org/10.1186/s13023-024-03264-0Koto Y., Narita A., Noto S., et al. Qualitative analysis of patient interviews on the burden of neuronopathic Gaucher disease in Japan. Orphanet J Rare Dis. 2022;17:280. https://doi.org/10.1186/s13023-022-02429-zKoto Y., Narita A., Noto S., et al. Qualitative analysis of patient interviews on the burden of neuronopathic Gaucher disease in Japan. Orphanet J Rare Dis. 2022;17:280. https://doi.org/10.1186/s13023-022-02429-z.Kirkham J.J., Gorst S., Altman D.G., et al. Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement. Trials. 2019;20:116. https://doi.org/10.1186/s13063-019-3230-xKirkham J.J., Gorst S., Altman D.G., et al. Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement. Trials. 2019;20:116. https://doi.org/10.1186/s13063-019-3230-xMüller A.R., Luijten M.A.J., Haverman L., et al. Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM. BMC Med. 2023;21:298. https://doi.org/10.1186/s12916-023-03012-4Müller A.R., Luijten M.A.J., Haverman L., et al. Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM. BMC Med. 2023;21:298. https://doi.org/10.1186/s12916-023-03012-4Hu X., Zhao Z., Zhang S.K., Luo Y., Yu H., Zhang Y. CA-PROM: Validation of a general patient-reported outcomes measure for Chinese patients with cancer. Cancer Epidemiol. 2020;67:101774. https://doi.org/10.1016/j.canep.2020.101774Xiaojuan Hu, Zhiqiang Zhao, Shao-Kai Zhang, Yanhong Luo, Hongmei Yu, Yanbo Zhang. CA-PROM: Validation of a general patient-reported outcomes measure for Chinese patients with cancer. Cancer Epidemiol. 2020;67:101774. https://doi.org/10.1016/j.canep.2020.101774Spennacchio P., Senorski E.H., Mouton C., et al. A new patient-reported outcome measure for the evaluation of ankle instability: description of the development process and validation protocol. J Orthop Surg Res. 2024;19:557. https://doi.org/10.1186/s13018-024-05057-4Spennacchio P., Senorski E.H., Mouton C., et al. A new patient-reported outcome measure for the evaluation of ankle instability: description of the development process and validation protocol. J Orthop Surg Res. 2024;19:557. https://doi.org/10.1186/s13018-024-05057-4Guruparan Y., Navaratinaraja T.S., Selvaratnam G., et al. Development and validation of a set of patient reported outcome measures to assess effectiveness of asthma prophylaxis. BMC Pulm Med. 2021;21:295. https://doi.org/10.1186/s12890-021-01665-6Guruparan Y., Navaratinaraja T.S., Selvaratnam G., et al. Development and validation of a set of patient reported outcome measures to assess effectiveness of asthma prophylaxis. BMC Pulm Med. 2021;21:295. https://doi.org/10.1186/s12890-021-01665-6

The authors declare that there are no conflicts of interest present.